Human APOBEC3B promotes tumor heterogeneity in vivo including signature mutations and metastases
暂无分享,去创建一个
R. Sotillo | R. Vogel | H. Nilsen | Sergio Carracedo | Rena Levin-Klein | Alicia Alonso de la Vega | L. Alsøe | P. Argyris | Cameron Durfee | N. Temiz | R. Harris | Joshua Proehl | Anna M. Holzhauer | Zachary J. Seeman | Yu-Hsiu T. Lin
[1] P. Span,et al. Clinical Implications of APOBEC3-mediated Mutagenesis in Breast Cancer. , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] Jeffrey S. Damrauer,et al. Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer , 2022, Nature Communications.
[3] M. Weitzman,et al. Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer , 2022, Nature Genetics.
[4] U. Ben-David,et al. Acute expression of human APOBEC3B in mice causes lethality associated with RNA editing , 2022, bioRxiv.
[5] M. Carpenter,et al. Mutational impact of APOBEC3B and APOBEC3A in a human cell line , 2022 .
[6] S. Di Giorgio,et al. Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination , 2022, Nature Reviews Genetics.
[7] Chun-long Chen,et al. Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers , 2022, Cell reports.
[8] D. Hanahan. Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.
[9] E. V. Van Allen,et al. Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance , 2020, bioRxiv.
[10] E. Koonin,et al. Mutation–selection balance and compensatory mechanisms in tumour evolution , 2020, Nature Reviews Genetics.
[11] D. Gordenin,et al. Hypermutation in single-stranded DNA , 2020, DNA Repair.
[12] D. Largaespada,et al. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo , 2019, bioRxiv.
[13] Johannes G. Reiter,et al. An analysis of genetic heterogeneity in untreated cancers , 2019, Nature Reviews Cancer.
[14] Steven L Salzberg,et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype , 2019, Nature Biotechnology.
[15] Lela Lackey,et al. A Rabbit Monoclonal Antibody against the Antiviral and Cancer Genomic DNA Mutating Enzyme APOBEC3B , 2019, bioRxiv.
[16] Rommie E. Amaro,et al. APOBEC3B Nuclear Localization Requires Two Distinct N-Terminal Domain Surfaces. , 2018, Journal of molecular biology.
[17] Fumiaki Ito,et al. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins. , 2017, Journal of molecular biology.
[18] Rommie E. Amaro,et al. Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B , 2016, Nature Structural &Molecular Biology.
[19] Xiaoyu Chen,et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..
[20] Z. Zeng,et al. Knockout of BRD7 results in impaired spermatogenesis and male infertility , 2016, Scientific Reports.
[21] C. Swanton,et al. APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity. , 2015, Cancer discovery.
[22] J. Dudley,et al. APOBECs and virus restriction. , 2015, Virology.
[23] Ryan M. Layer,et al. SpeedSeq: Ultra-fast personal genome analysis and interpretation , 2014, Nature Methods.
[24] R. Harris. Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer , 2015, Breast Cancer Research.
[25] T. Ludwig,et al. Male Fertility Defect Associated with Disrupted BRCA1-PALB2 Interaction in Mice* , 2014, The Journal of Biological Chemistry.
[26] Serena Nik-Zainal,et al. Mechanisms underlying mutational signatures in human cancers , 2014, Nature Reviews Genetics.
[27] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[28] Jason B. Nikas,et al. APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. , 2013, Cancer research.
[29] D. Gordenin,et al. The choice of nucleotide inserted opposite abasic sites formed within chromosomal DNA reveals the polymerase activities participating in translesion DNA synthesis. , 2013, DNA repair.
[30] N. A. Temiz,et al. Evidence for APOBEC3B mutagenesis in multiple human cancers , 2013, Nature Genetics.
[31] Lela Lackey,et al. Endogenous APOBEC3A DNA Cytosine Deaminase Is Cytoplasmic and Nongenotoxic* , 2013, The Journal of Biological Chemistry.
[32] N. A. Temiz,et al. APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.
[33] C. Schiffer,et al. Methylcytosine and Normal Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC3A* , 2012, The Journal of Biological Chemistry.
[34] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[35] W. Brown,et al. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction , 2010, Nucleic acids research.
[36] M. Stenglein,et al. APOBEC3 proteins mediate the clearance of foreign DNA from human cells , 2010, Nature Structural &Molecular Biology.
[37] M. Malim,et al. Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets , 2009, Journal of Virology.
[38] L. Hennighausen,et al. Cre-mediated gene deletion in the mammary gland. , 1997, Nucleic acids research.
[39] L. Hennighausen,et al. Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV‐LTR and the tetracycline responsive system , 1995, Journal of cellular biochemistry.
[40] K. Rajewsky,et al. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. , 1995, Nucleic acids research.
[41] M. Raff. Theta Isoantigen as a Marker of Thymus-derived Lymphocytes in Mice , 1969, Nature.